seeds25 Nov 2020 11:13
it is all in the rns's...
Joint Venture established with a European partner to establish a new base for cultivating the Company's high quality hemp seeds.
Expansion of seed testing programme
Zoetic is pleased to announce a partnership with cannabinoid research experts GVB Biopharma ("GVB"). The Company is confident in the value and strong cultivation potential of its seeds, and with its ongoing commitment to ensuring the highest quality products is now taking the additional step of verifying the quality of its base CBD assets through measurable channels.
With a bank of 40,000 feminized hemp seeds already under the care of GVB, planted in USDA certified ground, this growing season presents an opportunity to gather extensive data relating to their cultivation viability, along with the production of high-calibre CBD isolate. With Zoetic's seed stock due to be cultivated and tested in outdoor facilities, this represents the first large scale commercial hemp study and is a landmark achievement for the Company in its efforts to validate its genetic base.
Armed with the commercial intelligence generated both from GVB's research and the continuation of the existing testing programme by US universities, Zoetic will be well placed to accelerate its ongoing global product rollout whilst avoiding the reported difficulties faced by certain Kentucky and North Carolina based competitors with what appears to be genetically deficient hemp seed stocks